|1.||Wakabayashi, Toshihiko: 2 articles (01/2012 - 11/2009)|
|2.||Kajita, Yasukazu: 2 articles (01/2012 - 11/2009)|
|3.||Nakatsubo, Daisuke: 2 articles (01/2012 - 11/2009)|
|4.||Nishimuta, Yosuke: 1 article (09/2015)|
|5.||Karki, Prasanna: 1 article (09/2015)|
|6.||Nagayama, Tetsuya: 1 article (09/2015)|
|7.||Sugata, Sei: 1 article (09/2015)|
|8.||Arita, Kazunori: 1 article (09/2015)|
|9.||Tokimura, Hiroshi: 1 article (09/2015)|
|10.||Bohara, Manoj: 1 article (09/2015)|
|2.||Alzheimer Disease (Alzheimer's Disease)
04/01/1990 - "Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease."
07/01/1992 - "We used single photon emission computed tomography with the blood flow tracer [123I]N-isopropyl-p-iodoamphetamine (IMP) to study regional cerebral blood flow (rCBF) in 50 mildly and moderately demented Alzheimer's disease (AD) patients to evaluate rCBF as a function of disease severity. "
04/01/1990 - "To determine the diagnostic accuracy of iofetamine hydrochloride I 123 (IMP) with single photon emission computed tomography in Alzheimer's disease, we studied 58 patients with AD and 15 age-matched healthy control subjects. "
03/01/1987 - "We utilized single photon emission computed tomography and N-isopropyl-p-iodoamphetamine iodine 123 to evaluate regional cerebral blood flow in nine patients with Alzheimer's disease (AD), five healthy elderly control subjects, and two patients with multi-infarct dementia. "
04/01/1988 - "To determine whether abnormalities in regional cerebral functional activity estimated by iofetamine hydrochloride I 123 and single photon emission computed tomography can be detected in mild or moderate as well as severe cases of Alzheimer's disease (AD), we performed iofetamine I 123-single photon emission computed tomography in 37 patients with probable AD (nine patients with mild, 18 patients with moderate, and ten patients with severe dementia) and nine age-matched control subjects. "
|3.||Bipolar Disorder (Mania)
01/15/1997 - "I-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: a clinical study."
01/15/1997 - "The regional distribution of I-123 iofetamine (IMP) in the brain of 12 patients with rapid cycling bipolar disorder was studied by single-photon computed emission tomography imaging. "
01/01/1997 - "We evaluated total of 69 stroke patients with SPECT imaging using Iofetamine (I-123). "
01/01/1997 - "Correlation of functional independence measure (FIM) and SPECT Iofetamine (I-123) as a predictor of functional return in stroke."
09/01/1994 - "Early and delayed brain SPECT with technetium-99m-ECD and iodine-123-IMP in subacute strokes."
01/01/1989 - "When compared with CT in stroke patients, visualization may be performed sooner after symptom onset and a larger zone of involvement may be evident with iofetamine. "
03/01/1988 - "Iofetamine HCI I-123 brain scanning in stroke: a comparison with transmission CT."
09/01/1989 - "I-123 iofetamine single photon emission tomography in school-age children with difficult-to-control seizures."
01/01/1999 - "Although seizures did not occur at 9 years of age, she manifested dyscalculia, right-left disorientation, and finger agnosia, and N-isopropyl-p-iodoamphetamine single-photon emission computed tomography (SPECT) revealed focal hypoperfusion in the left parietal lobe. "
03/01/1991 - "Correlation of abnormalities of interictal n-isopropyl-p-iodoamphetamine single-photon emission tomography with focus of seizure onset in complex partial seizure disorders."
03/01/1993 - "We compared regional cerebral blood flow assessed by [123I]N-isopropyl-p-iodoamphetamine (IMP) single-photon emission tomography (SPECT) with magnetic resonance imaging (MRI), computed tomography (CT) and interictal surface electroencephalography (EEG) to evaluate its diagnostic potential in 24 patients with partial seizures with onset in childhood. "
03/01/1991 - "Single-photon emission tomography (SPECT) scanning with n-isopropyl-p-iodoamphetamine (IMP) was performed on 23 patients with complex partial seizures undergoing long-term video electroencephalographic (EEG) seizure monitoring. "
|1.||Inosine Monophosphate (IMP)
|3.||Iofetamine (Iofetamine Hydrochloride, I 123)
|6.||N,N,N'- trimethyl- N'- (2- hydroxy- 3- methyl- 5- iodobenzyl)- 1,3- propanediamine
|7.||5-methoxy-methylindoleacetic acid (DBI)
|8.||tranilast (N 5')
|1.||Deep Brain Stimulation
|3.||Gamma Cameras (Gamma Camera)